Tags

Type your tag names separated by a space and hit enter

[Management of central sleep apnea].
Rev Pneumol Clin. 2009 Aug; 65(4):261-72.RP

Abstract

Central sleep apnea is highly prevalent in association with heart failure, some neurological diseases and chronic opioids use. There are two main categories of central sleep apnea respectively related with different underlying conditions. Some hypocapnic patients exhibit respiratory control system instability and central apnea occurs when PaCO(2) falls below the threshold for apnea during sleep. The other group are patients with chronic hypercapnia mainly in the context of neuromuscular disorders or obesity hypoventilation syndrome. All these patients should be assessed by recording blood gases, polysomnography and ventilatory responses to CO(2). Cardiologic assessment should include pro-brain natriuretic factor (pro-BNP) and cardiac echography whereas neurological examination requires brain imaging and/or electromyography. Ventilatory supports used for treating central sleep apnea are non-invasive ventilation and servo-assisted ventilation in hypercapnic and hypocapnic patients respectively.

Authors+Show Affiliations

Laboratoire du sommeil et EFCR, pôle rééducation et physiologie , CHU de Grenoble, BP 217, 38043 Grenoble cedex 09, France.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

19789053

Citation

Boutin, I, et al. "[Management of Central Sleep Apnea]." Revue De Pneumologie Clinique, vol. 65, no. 4, 2009, pp. 261-72.
Boutin I, Saint-Raymond C, Borel JC, et al. [Management of central sleep apnea]. Rev Pneumol Clin. 2009;65(4):261-72.
Boutin, I., Saint-Raymond, C., Borel, J. C., Tamisier, R., Lévy, P., & Pépin, J. L. (2009). [Management of central sleep apnea]. Revue De Pneumologie Clinique, 65(4), 261-72. https://doi.org/10.1016/j.pneumo.2009.07.009
Boutin I, et al. [Management of Central Sleep Apnea]. Rev Pneumol Clin. 2009;65(4):261-72. PubMed PMID: 19789053.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Management of central sleep apnea]. AU - Boutin,I, AU - Saint-Raymond,C, AU - Borel,J-C, AU - Tamisier,R, AU - Lévy,P, AU - Pépin,J-L, Y1 - 2009/08/27/ PY - 2009/10/1/entrez PY - 2009/10/1/pubmed PY - 2009/12/16/medline SP - 261 EP - 72 JF - Revue de pneumologie clinique JO - Rev Pneumol Clin VL - 65 IS - 4 N2 - Central sleep apnea is highly prevalent in association with heart failure, some neurological diseases and chronic opioids use. There are two main categories of central sleep apnea respectively related with different underlying conditions. Some hypocapnic patients exhibit respiratory control system instability and central apnea occurs when PaCO(2) falls below the threshold for apnea during sleep. The other group are patients with chronic hypercapnia mainly in the context of neuromuscular disorders or obesity hypoventilation syndrome. All these patients should be assessed by recording blood gases, polysomnography and ventilatory responses to CO(2). Cardiologic assessment should include pro-brain natriuretic factor (pro-BNP) and cardiac echography whereas neurological examination requires brain imaging and/or electromyography. Ventilatory supports used for treating central sleep apnea are non-invasive ventilation and servo-assisted ventilation in hypercapnic and hypocapnic patients respectively. SN - 0761-8417 UR - https://www.unboundmedicine.com/medline/citation/19789053/[Management_of_central_sleep_apnea]_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0761-8417(09)00113-8 DB - PRIME DP - Unbound Medicine ER -